The Financial Burden of Stress Urinary Incontinence Among Women in the United States

Abstract

Stress urinary incontinence (SUI) is a common medical problem affecting 25% to 50% of women in the United States. This article reviews the literature on the current systems- and population-based costs of management of SUI in women. A PubMed search was conducted to seek studies examining the cost of various management options. Both nonsurgical and surgical management can effectively improve symptoms of SUI at a wide spectrum of costs. Over $12 billion are spent annually, an amount that continues to grow. Patients pay out-of-pocket for 70% of conservative management, amounting to a significant individual financial burden. Systems-based cost of SUI management continues to rise with the aging population. Costs to both individuals and systems may be mitigated if more patients are treated with intent to cure and as surgical management transitions from inpatient to outpatient procedures.

Cell-based Therapy for the Treatment of Female Stress Urinary Incontinence: An Early Cost–Effectiveness Analysis

“…Given the increasing demand of financial resources for the healthcare and taking into account the considerable economic impact of SUI [3][4][5], it is critical to perform early cost-effectiveness assessment of potential new regenerative medicine therapies. In this direction, this study provides a model to assess the cost-effectiveness of CBTs in comparison to the established MUS therapy for surgical management of SUI in women.…”

“…SUI describes a condition where there is an involuntary leak of urine when intra-abdominal pressure rises, for example, when coughing, sneezing, laughing or during other physical activity. SUI has not only a severe impact on quality of life but it also places a substantial economic burden on the healthcare system and society [3][4][5]. In the USA, for example, it has been estimated that in 1998, the average direct medical cost of SUI amounted US$5642 per patient, while the indirect workplace expenses were US$4208 [3].…”

“…In the USA, for example, it has been estimated that in 1998, the average direct medical cost of SUI amounted US$5642 per patient, while the indirect workplace expenses were US$4208 [3]. Evidence suggests that these costs have experienced an age-related increase over the last years [5].…”

“…In the USA, for example, it has been estimated that in 1998, the average direct medical cost of SUI amounted US$5642 per patient, while the indirect workplace expenses were US$4208 [3]. Evidence suggests that these costs have experienced an age-related increase over the last years [5].The clinical management of SUI is complex and may involve conservative treatments, such as pelvic floor muscle training and pharmacotherapy, as well as surgical procedures. Currently, the gold standard for surgical management of SUI in women is the midurethral sling (MUS), which displays a cure rate of 80-95% [6][7][8].…”

Validation of Turkish Version of Bristol Female Lower Urinary Tract Symptom Index

“…Ülkemizde farklı zamanlarda yapılan prevalans çalışmalarında inkontinans sıklığı %46,3-68 arasında bulunmuş, bunun üçte birinin stres tip inkontinans olduğu bildirilmiştir [5][6][7][8]. Amerika Birleşik Devletleri'nde hastalığın yıllık maliyeti 12 milyar USD olarak raporlanmış olup bu maliyetin yaşlanan nüfusun artışıyla daha da artacağı tahmin edilmektedir [9]. Klinik araştırmalarda kullanılan formların kolay anlaşılır, kısa ve rahat cevaplanabilir olması önemlidir.…”